Mirum Pharmaceuticals vs Rhythm Pharmaceuticals
MIRM and RYTM side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MIRM and RYTM compare
Rhythm Pharmaceuticals is the larger company, worth 1.3 times as much as Mirum Pharmaceuticals ($7.9B against $6.1B).
Rhythm Pharmaceuticals grew revenue faster over the last twelve months (53.5% versus 44.0% for Mirum Pharmaceuticals).
Rhythm Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of −85.6% compared with −139% at Mirum Pharmaceuticals.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MIRM | RYTM |
|---|---|---|
| Size and price | ||
| Market cap | $6.1B | $7.9B |
| Share price | $93.99 | $115.02 |
| Change, 1 year | 32.8% | 17.5% |
| Change, 5 years | 499% | 1017% |
| Beta (5Y) | 0.63 | 1.41 |
| Employees | 372 | 414 |
| StockData Score | ||
| Total score | 5 | 5 |
| Valuation score | 0 | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 1 | 1 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 9.9× (better) | 33.0× |
| P/B | – | 76.9× |
| FCF yield | −3.7% | – |
| Fair value | – | $31.48 |
| Margin of safety | – | −265% |
| Growth | ||
| Revenue growth (TTM) | 44.0% | 53.5% (better) |
| Profitability | ||
| Gross margin | – | 89.0% |
| Operating margin | −135% | −83.6% (better) |
| Net margin | −139% | −85.6% (better) |
| FCF margin | −37.0% | – |
| Return on equity | −703% | −451% (better) |
| Financial health | ||
| Debt / equity | – | 1.03 |
| Interest coverage | −62.1× | −10.9× (better) |
| Current ratio | 2.86 | 3.45 (better) |
| Altman Z-score | −0.14 | 16.80 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 110% | 112% |
| Held by insiders | 9.2% | 1.1% |
| Insider net buying, 12 months | −$31.5M (better) | −$36.0M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 11.1% | 17.1% |
Go deeper
- MIRM stock overview
- MIRM income statement
- MIRM valuation and score
- RYTM stock overview
- RYTM income statement
- RYTM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.